Skip to content
Recall Observatory FDA recall evidence

Drug product

Irbesartan Tablets USP, 300 mg a) 30 count (NDC 68180-412-06) and b) 90 count NDC# 68180-412-09) bottles, Rx only

D-0088-2022

October 12, 2021

Class II

Product summary

Firm
Lupin Pharmaceuticals Inc.
Event
Event 88856
Status
Terminated
Classification
Class II
Quantity
119,544 bottles
Official record key
drug-enforcement:D-0088-2022

Official wording

Reason: CGMP Deviations: impurity N-nitrosoirbesartan detected in API

Code information: a) Lot# H804310, exp. date 31/08/2021 H900050, exp. date 30/11/2021 H902262, exp. date 31/05/2022 b) Lot# H000845, exp. date 28/02/2023 H000846, exp. date 28/02/2023 H000965, exp. date 31/03/2023 H805345, exp. date 30/11/2021 H805346, exp. date 30/11/2021 H805347, exp. date 30/11/2021 H805724, exp. date 30/11/2021 H900061, exp. date 31/12/2021 H900062, exp. date 31/12/2021 H900445, exp. date 31/01/2022 H901489, exp. date 31/03/2022 H901490, exp. date 31/03/2022 H901491, exp. date 31/03/2022 H902261, exp. date 31/05/2022

Distribution pattern: Product was distributed to major distributors who may have further distributed the product nationwide.

Derived failure modes

  • Foreign material or chemical contamination

    reason.foreign_material_chemical_contamination · v1.0.0

    impurity N-nitrosoirbesartan detected in API
  • Manufacturing or process control

    reason.manufacturing_process_control · v1.0.0

    CGMP Deviations